• Users Online: 1687
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2017  |  Volume : 29  |  Issue : 2  |  Page : 54-58

Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients


1 Department of Biomedics, School of Medicine, University of North Sumatera, Medan, Indonesia
2 Division of Nephrology, Department of Internal Medicine, School of Medicine, University of North Sumatera/Haj Adam Malik Hospital and Rasida Hemodialysis Clinic, Medan, Indonesia
3 Division of Hepatogastroenterology, Department of Internal Medicine, University of North Sumatera/Haj Adam Malik Hospital, Medan, Indonesia
4 Division of Haematology, Department of Clinical Pathology, School of Medicine, University of North Sumatera/Haj Adam Malik Hospital, Medan, Indonesia
5 Department of Clinical Pathology, School of Medicine, University of North Sumatera/Haj Adam Malik Hospital, Medan, Indonesia

Correspondence Address:
Stephen C.L. Koh
Department of Clinical Pathology, School of Medicine, University of North Sumatera/Haj Adam Malik Hospital, Medan
Indonesia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejim.ejim_27_16

Rights and Permissions

Background The risk of chronic kidney disease stage 5 and its progression depend on the stage and the underlying diagnosis. Haemodialysis has become the long-term maintenance therapy for these patients. The interaction among interleukin-6 (IL-6), hepcidin and the iron exporter ferroportin is a major contributor to the iron-deficiency anaemia of chronic disease. The aim of the present study was to investigate the effects of polysulphone dialyzer membrane on serum IL-6 and hepcidin, including haemoglobin levels, in first-time patients undergoing five cycles of haemodialysis. Patients and methods Totally, 11 patients (male: five, female: six) were recruited for the present study after obtaining written informed consent. Their mean age was 57.4±13.4 years, and they were undergoing haemodialysis for the first time. Hepcidin, IL-6 and haemoglobin levels were determined before the first cycle and the fifth cycle and after the fifth cycle of haemodialysis. Pearson’s correlation coefficients were also determined. Results and discussion No statistically significant differences were observed before the first cycle and after the fifth cycle of haemodialysis in haemoglobin, IL-6 and hepcidin levels nor between pre-fifth and post-fifth cycle values, except for IL-6, which showed a significant mean reduction (P=0.04) from the pre-fifth cycle of 67.0 pg/ml to a mean value of 42.9 pg/ml (64.0% reduction). Analysis of variance showed no significant variation in the parameters studied, and no significant correlations between haemoglobin and IL-6, haemoglobin and hepcidin, and IL-6 and hepcidin were found. Conclusion In this short study of five-cycle haemodialysis, significant reduction in IL-6 with no significant change in hepcidin levels was found, even though severe anaemia was present. Kidney dysfunction probably results in decreased clearance of inflammatory markers and may not be improved by haemodialysis alone. Moreover, a different approach to reduce these markers is therefore warranted.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1880    
    Printed80    
    Emailed0    
    PDF Downloaded142    
    Comments [Add]    

Recommend this journal